1. Home
  2. LUCY vs INBS Comparison

LUCY vs INBS Comparison

Compare LUCY & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innovative Eyewear Inc.

LUCY

Innovative Eyewear Inc.

N/A

Current Price

$0.83

Market Cap

7.2M

Sector

Health Care

ML Signal

N/A

Logo Intelligent Bio Solutions Inc.

INBS

Intelligent Bio Solutions Inc.

N/A

Current Price

$1.99

Market Cap

6.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LUCY
INBS
Founded
2017
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Ophthalmic Goods
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2M
6.5M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
LUCY
INBS
Price
$0.83
$1.99
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 114.5K
22.6K
Earning Date
11-20-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 63.39
N/A
EPS
★ N/A
N/A
Revenue
★ $2,661,669.00
$1,980,484.00
Revenue This Year
$170.51
$44.72
Revenue Next Year
$205.56
$44.26
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 62.65
N/A
52 Week Low
$0.65
$0.54
52 Week High
$2.02
$24.90

Technical Indicators

Market Signals
Indicator
LUCY
INBS
Relative Strength Index (RSI) 44.17 61.86
Support Level $0.78 $1.52
Resistance Level $0.89 $2.45
Average True Range (ATR) 0.06 0.14
MACD -0.00 0.04
Stochastic Oscillator 52.01 92.16

Price Performance

Historical Comparison
LUCY
INBS

About LUCY Innovative Eyewear Inc.

Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok. The firm derive substantially all of its revenue from the sale of smart glasses and custom lenses.

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its current active product is the Intelligent Fingerprinting Platform, consisting of a proprietary portable platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader. Its flagship product, the Intelligent Fingerprinting Drug Screening System, is a two-part system of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse, including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Company operates in APAC, the UK, the Americas, and the rest of the world, with maximum revenue from the United Kingdom.

Share on Social Networks: